PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
743.76 - 757.57
479.80 - 796.25
8.25M / 11.73M (Avg.)
27.40 | 27.58
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
11.20%
Revenue growth at 50-75% of BIDU's 17.60%. Martin Whitman would worry about competitiveness or product relevance.
11.94%
Gross profit growth at 50-75% of BIDU's 18.06%. Martin Whitman would question if cost structure or brand is lagging.
25.85%
EBIT growth above 1.5x BIDU's 14.94%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
25.85%
Operating income growth above 1.5x BIDU's 14.94%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
27.49%
Net income growth above 1.5x BIDU's 15.28%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
21.43%
EPS growth 1.25-1.5x BIDU's 14.89%. Bruce Berkowitz would check if strategic initiatives like cost cutting or better capital management explain the difference.
30.77%
Diluted EPS growth above 1.5x BIDU's 14.89%. David Dodd would see if there's a robust moat protecting these shareholder gains.
0.93%
Share count expansion well above BIDU's 0.03%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
1.04%
Diluted share count expanding well above BIDU's 0.14%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
-28.14%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-36.81%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
106.76%
10Y revenue/share CAGR under 50% of BIDU's 28360.71%. Michael Burry would suspect a lasting competitive disadvantage.
106.76%
5Y revenue/share CAGR under 50% of BIDU's 847.73%. Michael Burry would suspect a significant competitive gap or product weakness.
106.76%
3Y revenue/share CAGR similar to BIDU's 112.36%. Walter Schloss would assume both companies experience comparable short-term cycles.
64.51%
OCF/share CAGR of 64.51% while BIDU is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
64.51%
OCF/share CAGR of 64.51% while BIDU is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
64.51%
3Y OCF/share CAGR of 64.51% while BIDU is zero. Bruce Berkowitz might see if small gains can expand into a broader advantage.
81.89%
Below 50% of BIDU's 44694.01%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
81.89%
Below 50% of BIDU's 757.99%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
81.89%
3Y net income/share CAGR 1.25-1.5x BIDU's 61.53%. Bruce Berkowitz might see new markets, M&A, or better cost discipline driving the difference.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
11.51%
AR growth well above BIDU's 22.13%. Michael Burry fears inflated revenue or higher default risk in the near future.
No Data
No Data available this quarter, please select a different quarter.
-5.03%
Negative asset growth while BIDU invests at 22.03%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
4.68%
Under 50% of BIDU's 11.71%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-73.47%
We’re deleveraging while BIDU stands at 51.21%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
7.27%
R&D dropping or stable vs. BIDU's 15.80%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
-8.60%
We cut SG&A while BIDU invests at 28.42%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.